We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+2.63%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.2B
AUM Growth
-$91.8M
(-1.7%)
Cap. Flow
-$238M
Cap. Flow
% of AUM
-4.58%
Top 10 Holdings %
Top 10 Hldgs %
22.29%
Holding
328
New
43
Increased
93
Reduced
100
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$38.2M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$37.7M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$35.3M |
| 4 |
Icon
ICLR
|
+$30.9M |
| 5 |
CELG
Celgene Corp
CELG
|
+$29.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$63.8M |
| 2 |
Danaher
DHR
|
+$50.4M |
| 3 |
AutoZone
AZO
|
+$36.8M |
| 4 |
AGN
Allergan plc
AGN
|
+$33.9M |
| 5 |
Biogen
BIIB
|
+$33.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Healthcare | 24.38% |
| 3 | Financials | 20.66% |
| 4 | Communication Services | 10.61% |
| 5 | Consumer Discretionary | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.89T
| $256M | 4.93% |
8,176,324
-567,788
| -6% | -$18.2M |
|
2
Alphabet (Google) Class C
GOOG
$3.9T
| $200M | 3.86% |
7,609,460
-377,809
| -5% | -$10.1M |
|
3
Pfizer
PFE
$140B
| $137M | 2.64% |
4,312,352
-270,742
| -6% | -$8.82M |
|
4
Chubb
CB
$140B
| $93.9M | 1.81% |
923,704
+21,190
| +2% | +$2.28M |
|
5
Medtronic
MDT
$107B
| $88.7M | 1.71% |
1,197,573
+31,000
| +3% | +$2.37M |
|
6
Meta Platforms (Facebook)
META
$1.51T
| $83.4M | 1.6% |
972,593
-106,985
| -10% | -$8.74M |
|
7
Thermo Fisher Scientific
TMO
$211B
| $80.1M | 1.54% |
617,391
-27,208
| -4% | -$3.55M |
|
8
Arch Capital
ACGL
$36.1B
| $77.4M | 1.49% |
3,467,274
+100,449
| +3% | +$2.13M |
|
9
Markel Group
MKL
$25B
| $70.8M | 1.36% |
88,362
+22,975
| +35% | +$17.9M |
|
10
JPMorgan Chase
JPM
$939B
| $70.3M | 1.35% |
1,037,368
-14,401
| -1% | -$940K |
|
11
Visa
V
$677B
| $69.2M | 1.33% |
1,030,062
+192,150
| +23% | +$13M |
|
12
Citigroup
C
$222B
| $64.5M | 1.24% |
1,167,715
-31,154
| -3% | -$1.69M |
|
13
Microsoft
MSFT
$2.84T
| $63.6M | 1.22% |
1,440,995
+442,142
| +44% | +$20.2M |
|
14
Intel
INTC
$464B
| $61.3M | 1.18% |
2,016,530
+855,081
| +74% | +$27.6M |
|
15
Johnson & Johnson
JNJ
$634B
| $60.5M | 1.16% |
621,293
+188,581
| +44% | +$18.9M |
|
16
Accenture
ACN
$89.9B
| $56.8M | 1.09% |
586,894
+78,826
| +16% | +$7.53M |
|
17
Oracle
ORCL
$331B
| $56.3M | 1.08% |
1,396,852
-66,229
| -5% | -$2.87M |
|
18
Elevance Health
ELV
$81.9B
| $55.6M | 1.07% |
338,626
-61,910
| -15% | -$9.89M |
|
|
TWX
19
DELISTED
Time Warner Inc
TWX
| $55.2M | 1.06% |
631,671
-115,320
| -15% | -$9.84M |
|
20
Lazard
LAZ
$4.37B
| $53.9M | 1.04% |
957,582
-209,530
| -18% | -$11.7M |
|
21
Aon
AON
$77.3B
| $53.3M | 1.03% |
534,649
-105,808
| -17% | -$10.6M |
|
|
QVCGA
22
DELISTED
QVC Group Inc Series A
QVCGA
| $52.8M | 1.02% |
39,227
+98
| +0.3% | +$136K |
|
|
AET
23
DELISTED
Aetna Inc
AET
| $51.2M | 0.99% |
401,921
+14,377
| +4% | +$1.64M |
|
24
Fidelity National Information Services
FIS
$21.5B
| $50.7M | 0.98% |
820,435
-253,912
| -24% | -$16.3M |
|
25
Comcast
CMCSA
$79.7B
| $50.6M | 0.97% |
1,681,274
| – | – |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Polar Capital held 328 positions worth $5.2B, down 1.7% from $5.29B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Polar Capital withdrew a net $238M in Q2 2015, closing 61 positions and reducing 100 holdings. Its most notable exit was Danaher, an estimated $50.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Polar Capital opened a new position in Stryker worth $38.5M.
- Polar Capital's largest Q2 2015 buy was Stryker: 402,973 shares worth $38.5M.
- Polar Capital added most to Celgene Corp in Q2 2015, an estimated $29.8M increase.
- Polar Capital's biggest Q2 2015 reduction was Merck, cutting an estimated $63.8M.
- Polar Capital fully exited Danaher in Q2 2015, selling an estimated $50.4M.
- Polar Capital's ten largest holdings make up 22% of its $5.2B portfolio in Q2 2015.
- Polar Capital opened 43 new positions and closed 61 in Q2 2015.
- Polar Capital's portfolio value fell 1.7% quarter-over-quarter to $5.2B.
Based on Polar Capital's 13F filing for Q2 2015, filed 14 Aug 2015.